After years of trying, Congress is finally on the verge of passing legislation aimed at lowering prescription drug prices by targeting the intermediaries that help negotiate them.
2025 Health Care Outlook: Susan Cantrell, AMCP
With President Trump and his administration returning to Washington, D.C., and a new Congress set to take shape, there’s naturally some uncertainty when it comes to the future of American health care policy. Looking ahead to 2025, however, there will likely be some key decisions affecting and defining how managed care pharmacy and the larger health care system operate and serve patients.
Related
Write-ups of presentations on the 340B Drug Pricing Program were among the most viewed conference-related articles on the MHE website in 2025. At the 2025 AMCP annual meeting in Houston, John M. O'Brien, Pharm.D., M.P.H., president and CEO of the National Pharmaceutical Council, shared concerns and potential reforms in a conversation with Managed Healthcare Executive.
At last year’s Academy of Managed Care Pharmacy (AMCP) Nexus conference, the poster presentations underscored a pivotal transition in how the industry views mental health and neurology—moving beyond simple symptom management to a holistic evaluation of functional outcomes and economic burden. To delve into these findings, The American Journal of Managed Care® (AJMC®) spoke with Mitzi Wasik, PharmD, executive director at the AMCP Foundation, via email for insights on the recurring themes of the meeting.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
